文献速递术前评估与围术期医学

克隆性造血与食管癌根治术后严重并发症相关

Association of clonal haematopoiesis with severe postoperative complications in patients undergoing radical oesophagectomy.
PubMed 文献 · Br J Anaesth · 2023-12-02

这项单中心前瞻性观察研究纳入156例食管癌根治术患者,通过血液DNA测序定义克隆性造血(CH)。CH发生率为21.2%,CH患者严重术后并发症(Clavien-Dindo≥3)发生率显著高于无CH者(42.4% vs 22.8%,P=0.024),多因素分析示CH与严重并发症风险增加相关(OR=3.63,95%CI 1.37-9.66,P=0.010)。

要点

  • 食管癌根治术患者CH发生率为21.2%。
  • CH患者严重术后并发症发生率更高(42.4% vs 22.8%)。
  • CH与严重并发症风险增加独立相关(OR=3.63)。

核心结论

  • 克隆性造血与食管癌根治术后严重并发症发生率升高相关,提示其在围术期医学中可能具有重要作用。

研究设计与样本

  • 单中心前瞻性观察研究,纳入156例接受食管癌根治术的患者,采集外周血进行DNA测序。
  • CH定义为DNMT3A基因、TET2基因或两者同时存在造血体细胞突变且变异等位基因频率≥1%。

主要发现

  • CH发生率为21.2%(33/156),患者平均年龄66岁(范围26-79岁),男性占83%。
  • CH患者严重术后并发症(Clavien-Dindo≥3)发生率为42.4%(14/33),无CH者为22.8%(28/123),P=0.024。
  • 多因素logistic回归显示CH与严重术后并发症风险增加相关(OR=3.63,95%CI 1.37-9.66,P=0.010)。
  • CH患者肺部并发症发生率显著高于无CH者(45.5% [15/33] vs 24.4% [30/123],P=0.018)。

临床怎么用

  • 对接受食管癌根治术的患者,可考虑检测CH相关体细胞突变以辅助术后并发症风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clonal haematopoiesis (CH) is an age-associated clonal expansion of blood cells driven by leukaemia-associated somatic mutations. Although CH has been reported to be a risk factor for leukaemia and a number of non-haematopoietic diseases, its role in perioperative medicine remains unexplored. METHODS: This was a single-centre, prospective, observational study. Patients undergoing radical oesophagectomy were enrolled, and peripheral blood samples were collected for DNA sequencing. Patients with haematopoietic somatic mutations (variant allele frequencies ≥1%) in the DNMT3A gene, TET2 gene, or both were defined as CH carriers. The primary outcome was the incidence of severe postoperative complications (Clavien-Dindo classification ≥3). The secondary outcomes included the major types of postoperative complications, mortality, and other common perioperative variables. RESULTS: Clonal haematopoiesis was found in 21.2% (33/156) of the patients (mean age: 66 yr [range: 26-79 yr]; 83% males). Some 14/33 (42.4%) patients with CH had severe postoperative complications, compared with patients without CH carriers (28/123 [22.8%]; P=0.024). Multivariable logistic regression analysis showed that CH was associated with an increased risk of developing severe postoperative complications (odds ratio, 3.63; 95% confidence interval, 1.37-9.66; P=0.010). Among the major postoperative complications, the incidence of pulmonary complications was significantly higher in the patients with CH than in those without CH (15 in 33 [45.5%] vs 30 in 123 [24.4%], P=0.018). CONCLUSIONS: Clonal haematopoiesis was associated with a higher incidence of severe postoperative complications in patients undergoing radical oesophagectomy, suggesting that clonal haematopoiesis can play an important role in perioperative medicine. CLINICAL TRIAL REGISTRATION: ChiCTR2100044175 (Chinese Clinical Trial Registry, http://www.chictr.org.cn/showproj.aspx?proj=123193).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Wang H, Yan H, Chen W, et al. Association of clonal haematopoiesis with severe postoperative complications in patients undergoing radical oesophagectomy. Br J Anaesth. 2023. PMID: 38044238. doi:10.1016/j.bja.2023.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。